Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway
Table 2
Responses of 19 AML patients enrolled in the study.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Responses of 19 AML patients enrolled in the study.